Wanbangde Pharmaceutical Holding Group Co Ltd Strategic Asset Allocation Index
Wanbangde Pharmaceutical Holding Group Co Ltd strategic asset allocation index. Wanbangde Pharmaceutical Holding Group Co Ltd (002082) has a Strategic Asset Allocation Index of 51.4% as of June 2023. Strategic assets (PP&E of CN¥1.42 Billion plus long-term investments of CN¥-) total CN¥1.42 Billion, measured against net assets of CN¥2.77 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check tangible net worth ratio of Wanbangde Pharmaceutical Holding Group C to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Wanbangde Pharmaceutical Holding Group Co Ltd (2003–2021)
Strategic asset allocation index of Wanbangde Pharmaceutical Holding Group Co Ltd from 2003 to 2021. This chart shows how Wanbangde Pharmaceutical Holding Group Co Ltd's Strategic Asset Allocation Index has evolved across 19 annual periods from 2003 to 2021. As of June 2023, the index stands at 51.4%, representing strategic assets of CN¥1.42 Billion against net assets of CN¥2.77 Billion CNY.
Wanbangde Pharmaceutical Holding Group Co Ltd Strategic Asset Allocation Index by Year (2003–2021)
Wanbangde Pharmaceutical Holding Group Co Ltd strategic asset allocation index by year from 2003 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Wanbangde Pharmaceutical Holding Group Co Ltd from 2003 to 2021, covering 19 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 002082 company net worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 42.8% | CN¥1.18 Billion | CN¥1.18 Billion | CN¥- | CN¥2.74 Billion | ▼ -18.0 pp |
| 2020 | 60.8% | CN¥1.74 Billion | CN¥1.74 Billion | CN¥- | CN¥2.86 Billion | ▼ -3.7 pp |
| 2019 | 64.5% | CN¥1.23 Billion | CN¥1.23 Billion | CN¥- | CN¥1.91 Billion | ▲ +48.4 pp |
| 2018 | 16.2% | CN¥278.60 Million | CN¥278.60 Million | CN¥- | CN¥1.72 Billion | ▼ -15.6 pp |
| 2017 | 31.8% | CN¥509.95 Million | CN¥509.95 Million | CN¥- | CN¥1.60 Billion | ▲ +2.9 pp |
| 2016 | 28.9% | CN¥403.55 Million | CN¥403.55 Million | CN¥- | CN¥1.40 Billion | ▼ -4.6 pp |
| 2015 | 33.5% | CN¥451.11 Million | CN¥451.11 Million | CN¥- | CN¥1.35 Billion | ▼ -2.2 pp |
| 2014 | 35.7% | CN¥462.27 Million | CN¥462.27 Million | CN¥- | CN¥1.30 Billion | ▼ -9.3 pp |
| 2013 | 45.0% | CN¥534.18 Million | CN¥534.18 Million | CN¥- | CN¥1.19 Billion | ▼ -10.0 pp |
| 2012 | 55.0% | CN¥603.37 Million | CN¥603.37 Million | CN¥- | CN¥1.10 Billion | ▼ -3.7 pp |
| 2011 | 58.7% | CN¥618.82 Million | CN¥618.82 Million | CN¥- | CN¥1.05 Billion | ▼ -0.6 pp |
| 2010 | 59.3% | CN¥555.12 Million | CN¥555.12 Million | CN¥- | CN¥936.13 Million | ▼ -13.2 pp |
| 2009 | 72.5% | CN¥588.26 Million | CN¥588.26 Million | CN¥- | CN¥811.59 Million | ▼ -6.7 pp |
| 2008 | 79.2% | CN¥563.86 Million | CN¥563.86 Million | CN¥- | CN¥712.31 Million | ▼ -28.9 pp |
| 2007 | 108.1% | CN¥448.58 Million | CN¥448.58 Million | CN¥- | CN¥415.12 Million | ▲ +9.8 pp |
| 2006 | 98.3% | CN¥351.63 Million | CN¥351.63 Million | CN¥- | CN¥357.72 Million | ▼ -103.2 pp |
| 2005 | 201.5% | CN¥308.10 Million | CN¥308.10 Million | CN¥- | CN¥152.88 Million | ▲ +33.5 pp |
| 2004 | 168.0% | CN¥228.80 Million | CN¥228.80 Million | CN¥- | CN¥136.17 Million | ▲ +29.2 pp |
| 2003 | 138.8% | CN¥136.77 Million | CN¥136.77 Million | CN¥- | CN¥98.53 Million | — |